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Prevalence and complications of liver cysts (LC) in adult-type polycystic
kidney disease (PKD). G. Albouze, J. P. Grunfeld, P. Jungers, A. Dana,
B. Lafforgue, A. Moynot, D. Droz, P. Landais, and J. M. Idatte.
Clinique Nephrologique, Hôpital Necker; A.U.R.A., Paris, France.
We evaluated, by ultrasonography, the prevalence of LC in three
groups of patients with PKD: (1) In a prospective study in 1982, we
investigated 124 dialysis patients (74 females, 56.9 9.3 years, mean
SD; 50 males, 54.9 8.8 years). LC were detected in 85 of them
(68.5%): 75% in females and 62% in males (x2 = 1.65, NS). (2) In a
retrospective study, we estimated the prevalence of LC in 120 nondia-
lyzed patients with PKD. The prevalence of LC is higher in females
(45.3 14.3 years) than in males (44.7 15.0 years): 50 of 68 females
(73%) and 23 of 52 males (44%) (x2 = 10.6; P <0.01). (3) We studied the
incidence of complications related to LC in a group of 229 patients with
PKD, treated by periodic dialysis in the 1965 to 1982 period. Seventy-
six patients died during this period, including eight from LC complica-
tions: infection, 4; portal hypertension, 2; and cholangiocarcinoma, 2.
Three additional patients had severe but not fatal, infectious complica-
tions of LC. In conclusion, (1) in dialysis patients with PKD, the
prevalence of LC found by ultrasonography is approximately 70%; (2) it
increases in males between 40 and 60 years of age; the development of
LC seems to occur earlier in females; (3) the complications of LC are
frequent and often severe, responsible for death in 10% of the dialysis
patients.
Critical role of oxalate restriction (OxR) in association with calcium
restriction (CaR) in decreasing the probability stone formation (PSF):
insufficient effect in idiopathic hypercalciuria (Ill). P. Bataille, I. Gre-
goire, G. Charransol, A. Pruna, J. F. de Fremont, B. Coevoet, C. Galy,
and A. Fournier. Centre Hospitalo-Universitaire, Amiens, et Institut
Hydrologie Paris, France. Simple dietary CaR increases Ox excretion
in all subgroups of calcium stone formers (CaSF), and in IH increases
the PSF index of Robertson. Therefore, PSF was calculated in three
groups of idiopathic CaSF [normocalciuric (NC), dietary hypercalciuric
(DH), and IH, the latter group being defined by Ca excretion > 3 mg/kg
on a CaRD of 400 mg/day] in four conditions: free diet, on a Ca and
oxalate-restricted diet (Ca, 0x) during 4 days, and after an oxalate
load (200 g of spinach) while on a Ca free (Ca+) and on a CaRD (Ca—).
PSF (absolute) PSF wit
Ca+
h Ox load
Ca—Free diet Ca—Ox—
NCa (N = 18)
DH (N = 7)
IH (N = 17)
0,56
0.80
0.77
0.44"
0.48b
0.68
+0.11
+0.06
+0.02
+O.27
+0.36b
+0.24
a P < 0.02; P < 0.01.
The table shows that combined Ca and Ox dietary restriction signifi-
cantly decreases PSF only in NCa and DH. In IH the decrease in PSF is
not significant because oxalate excretion significantly increases (33 —
39 mg/day; P < 0.02) when dietary calcium is restricted despite
concomitant oxalate restriction. The oxalate load significantly increases
the PSF in all subgroups only when dietary calcium is restricted. In
conclusion, (1) in all CaSF concomitant oxalate restriction is critical to
lessen the oxalate excretion increase induced by a CaR diet. (2). In IH,
however, this effect is not sufficient to significantly decrease the PSF,
suggesting that additional measures are necessary.
Aluminum and renal osteodystrophy. Y. Berland, M. Grandvuillemin,
S. Charon, M. Olmer, and C. Andonian. Service de Nephrologie,
Hôpital de Ia Conception, Marseille, France. An investigation for bone
deposits of aluminum (Al) by colorimetric method (aurin tricarboxylic
acid) was performed in 41 patients with chronic renal failure, 35
hemodialyzed and 6 nonhemodialyzed, with a double objective: to
assess the role of different sources of aluminum intake in these uremic
patients and the histomorphometric incidence. The six nonhemodia-
lyzed patients presented no deposition. For eight hemodialyzed patients
the colorations were positive (Al+) with variable intensity (+++, ++,
+). The serum aluminum level was 93 44.46 tg/liter (mean 5EM) in
this group of eight patients and 41.78 18.32 pg/liter in the group of 27
hemodialyzed patients in whom the colorations were negative (Al—).
There was no significant difference in the duration of hemodialysis
between the Al+ and Al— groups. The cumulative doses of Al(OH)3
ingested were equivalent: Al+ = 8.3 kg, Al— = 9.1 kg. In contrast, all
the Al+ uremic patients were dialyzed with softened water while 75%
of the Al— group were dialyzed with water treated by reverse osmosis.
In the Al+ group, histomorphometric study revealed lesions of osteo-
malacia (rate of mineralization < 0.60 pm/day) in three patients and
hyperparathyroidism (HPT) in five other patients. In the Al— group, 23
patients had hyperparathyroidism. The relative osteoid volume was
significantly higher in the Al+ group (20.87 13.5%) than in the Al—
group (7.3 4.69%, P < 0.001). The strongest strains (+++ and ++)
were observed in two of the patients having osteomalacia and in three
cases of hyperparathyroidism. In conclusion, (1) dialysis water seems
to be the essential cause of bone intoxication by aluminum. (2) Deposits
of Al— in bone favor osteomalacia and hyperosteoidosis. (3) The most
intense deposits can be associated with both lesions of osteomalacia
and of hyperparathyroidism.
Sodium-dependent transcellular water shift during dialysis. J. P.
Brunois, R. Vistelle, 0. Toupance, G. Vantard, J. M. Malbrancq, and
J. Chanard. Service de Nephrologie, Centre Hospitalier et Universi-
taire, Reims, et Centre de Recherche Rhône-Poulenc-Hospal, Vitrv,
France. Symptomatic hypotension and other symptoms of the so-called
dialytic disequilibrium syndrome have been related to differences in
body fluid distribution. Fluid removal from the intracellular compart-
ment can be achieved by modifying the dialysate sodium (Na0). Total
body water and extracellular fluid volume (ECFV) measured with inulin
and/or 35S04 diffusion spaces were monitored in 15 patients hemodia-
lyzed with a highly permeable membrane and careful monitoring of
ultrafiltration. NaD level was between 140 and 170 mmoles/liter and was
maintained constant throughout the session. Below 150 mmoles/liter
Na0, ECFV was reduced more than weight loss, indicating concomitant
intracellular water loading. Conversely, over 150 mmoles/liter, Na0
weight drop was due to extracellular and cellular water loss. Predicted
postdialysis sodium levels according to Gotch's model did not fit with
experimental values when Na0 was above 150 mmoles/liter. We used
the experimental values to devise a simplified model that links plasma
sodium with ECFV. The model is based on the assumption that only
sodium governs the water shift between cellular and extracellular
compartments. Calculations were derived from sodium and water mass
conservation equations during dialysis. We conclude that (1) transcellu-
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lar water shift during dialysis is dependent on dialysate sodium; (2) net
cellular water-shift is obtained at NaD above ISO mmoles/liter; (3) at
least two water distribution compartments should be evaluated for
sodium modeling.
Prospective study of urinary sodium excretion in the cirrhotic patient
before and after peritoneoveinous (Le veen) shunt (PVS) insertion. S.
Dard, P. de-Mesrier, M. Cerf, and J. P. Mérv. HOpital Bichat, Paris,
France. Nine cirrhotic patients with intractable ascite in whom a PVS
had been inserted were studied prospectively for urinary sodium
excretion and various parameters [urinary sodium excretion (UN),
creatinine clearance (Ccr), plasma volume (VP), plasma renin activity
(PRA), plasma aldosterone (PA), and antidiuretic hormone (ADH)I at
the end of two periods of 10 days each during which they received 100
mmoles of sodium per day and no diuretic. According to the patients,
the first period started between 13 and 15 days before the shunt
insertion, the second between 15 and 20 days after it. Results (mean
value SEM) are as follows:
UNa
mrnoles day
Ccr
ml min1
PV
m1 kg'
Before PVS
After PVS
6.1 4
69 Il
P<0.05
65.5 10
79 9
NS
36 1.1
50 1.4
P<0.05
Before PSV
After PVS
PRA
ng m/ hr' PApg• ml ADHapg m11
19 4
2.5 0.8
P<0.05
658 33
160 63
P<0.05
8.34 1.4
3.1 0.7
P<0.05
Five patients; statistical evaluation: Wilcoxon's test.
In conclusion, this study shows that in cirrhotic patients receiving a
normal sodium diet the insertion of a PVS is followed by (1) a major
increase in PV together with a normalization of PRA, PA, and ADH; (2)
an increase in urinary sodium excretion which, however, remains
inferior to the sodium ingested; this abnormality might be due to the
lack of correction by the PVS of a deficit in prostaglandins and/or
natriuretic factor.
Measurement of "natriuretic factor" in the plasma of essential hyper.
tensive subjects. H. de The, M. G. Pernollet, J. F. Cloix, I. Wauguier, J.
L. Elghozi, J. Rosenfeld, M. A. Devynck, and P. Meyer. Institut
National de Ia Sante et de Ia Recherche Medicate Unite 7, Necker
Hospital, Paris, France. Endogenous substances with digitalis-like
properties have been extracted from several tissues. Ouabain injections
increase vascular resistance. The use of various techniques suggested
that such factors are increased in some forms of animal or human
hypertension. To prove the existence of such a 'natriuretic factor" in
human plasma, three groups of subjects were studied: untreated essen-
tial hypertensives (N = 22), normotensives with a family history of
hypertension (N = 16), and normotensives without a family history of
hypertension (N = 17) (control group). Two convergent methods were
used: decrease in the affinity of ouabain binding to its target cells and
inhibition of the Na*_K± dependent ATP hydrolysis tested on purified
enzyme. A significant correlation between the two methods was found
(r = 0.76, N = 47, P < 0.01) suggesting that the same factor is
responsible for both effects. Plasmatic levels of natriuretic factor are
higher in the hypertensive and positive heredity groups compared to
controls (P < 0.002). This factor is clearly present in half of the
hypertensives and some of their offspring, showing that there is no
simple relationship between natriuretic factor and arterial blood
pressure.
Cardiac arrhythmia in chronic dialysis patients. M. Kessler, E. A/jot,
M. C. Vignon, C. Huriel, andJ. M. Gilgenkrantz. Service de NCphrolo-
gie, Centre Hospitalier Regional de Brabois, Vandoeuvre, et Service de
Cardiologie, Centre Hospitalo-Universitaire, Nancy, France. Heart
function in dialysis patients has been well studied but very few papers
have been devoted to arrhythmia. We performed a Holter monitoring in
20 stable patients, 11 females and 9 males, with a mean age of 53.6 years
(19 to 76). They had been treated by chronic hemodialysis for 35.15
months (3 to 145). The observation period was 44 hr: 21.3 hr predialysis,
5.1 hr during dialysis, and 17.6 hr postdialysis. In 12 patients standard
EKG was not modified before and after dialysis, six patients showed
improvement and in two patients abnormalities appeared after dialysis.
We observed severe ventricular arrhythmia in 50% of these patients and
supraventricular arrhythmia in 60%. Dialysis did not influence the
frequency of abnormalities, which increased or decreased after dialysis.
In the group with severe ventricular extrasystoles, the mean age was
higher (64.3 years), cardiothoracic index was abnormal (0.56), and
predialytic kalemia was higher. All these patients had cardiac involve-
ment and three patients were treated with digoxin.
Antistreptococcal antibodies and glomerulonephritis (GN). G. Lagrue,
J. Laurent, J. C. Torlotin, and I. Cessot. Inst itut National de Ia SantE
et de Ia Recherche Medical, UnitE 139, Hôpital Henri Mondor, CrEteil,
et Hôpital Herold, Paris, France. The streptococcal origin of acute GN
is well established. Conversely, the cause of most chronic GN is
unknown; only rarely has a definite episode of acute GN or a rise in
antistreptolysines 0 (ASOT) been demonstrated. We studied the preva-
lence of four streptococcal exoproteins: ASOT, antistreptodornase B
(ASDB), antihyaluronidase, and antistreptokinase in 115 chronic GN.
Fifty-four percent of these subjects had elevation of at least one of these
antibodies, in most cases ASDB. The positivity of other antibodies in
frequency of positive subjects and in titer was comparable to that seen
in controls. Elevation of ASDB was found frequently in IgA nephrop-
athy (57%) and membranoproliferative GN (MPGN) (62%), often at
high titers. This anomaly was also found in GN with extraniembranous
deposits (42%). Abnormal ASDB levels were seen in 17% of controls.
These findings were significant at P < 0.001 in the cases of IgA
nephropathy and GNMP and at P < 0.01 for MG by y2 analysis. These
tests were normal in lipoid nephrosis and segmental focal glomerulo-
sclerosis. Results did not correlate with the level of proteinuria or with
the presence of nephrotic syndrome. In conclusion, IgA nephropathy,
MPGN and MG are often associated with high levels of ASDB. This
may reflect a previous or latent streptococcal infection, particularly
with serotype 12, a major source of streptodornase B, or an otherwise
anomalous humoral immune response. These results also suggest that
measurement of ASDB may be more informative than measurement of
ASOT.
Postvaccination lipoid nephrosis and allergy to egg proteins. J. Lau-
rent, G. Lagrue, J. Sainte-Laudy, E. Pirotsky, and A. Eyquem. Institut
National de ta Sante et de Ia Recherche Medical, Unite 139, Hópital
Henri Mondor, CrEteil, France. Postvaccination renal diseases are rare.
Lipoid nephrosis (LN) has been reported, but the pathogenetic
mechanisms involved are not understood. Pepys showed that hypersen-
sitivity to eggs could explain allergic manifestations following some
anti-viral vaccinations. We observed four patients with proteinuria of
which three had nephrotic syndrome that appeared or reappeared
following vaccination against poliomyelitis, two with focal segmental
glomerulosclerosis, and two with minimal change disease on renal
biopsy. Each of these four patients had some evidence of hypersensitiv-
ity to eggs: one of four had a positive skin test to egg white; two of two
had precipitins against ovalbumin: two of four had a positive basophil
degranulation test with egg proteins; specific IgG four were found in
four of four; no specific IgE (RAST) was detected in the three patients
assayed. In one patient dietary withdrawal and reintroduction of eggs
demonstrated the role of this allergen in the degree of proteinuria. In
another case, the absence of eggs in the diet coupled with the use of
anti-allergic medications (cromoglycate and ketotifen) led to a reduction
in proteinuria (from 10 g/24 hr to 3 g/24 hr) and a stabilization of
creatinine levels at 200 jimoles/liter. Hypersensitivity to egg proteins
should be assessed prior to the use of egg-containing vaccines in
patients with previous or present GN. Allergy to commonly ingested
products may play a role in some LN and should be routinely
considered.
Cimetidine in primary hyperparathyroidism (PHPT): Lack of effect
lowering on plasma levels of calcium and immunoreactive parathyroid
hormone (iPTH). D. Line, J. M. Hardin, J. L. Seberr, J. GuEris, A.
Bourdeau, C. Galy, R. Makdassi, and A. Fournier. Centre Hospitalo-
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Universitaire, Amiens, Hôpital Lariboisière, et Hôpital Necker, Paris,
France. Discrepant results after cimetidine in PHPT may be explained
by the small number of observations and uncertainties in diagnosis and
PTH radioimmunoassy results. We report here the effect of cimetidine
at a daily dose of 1200 mg in 14 patients with PHPT where diagnosis was
based on the coexistence of otherwise unexplained hypercalcemia
(corrected calcemia > 10.5 mg/dl) and of elevated iPTH plasma levels
measured by two different antibodies, one specific for C terminal
fragments and the other for 44 to 68 medium fragments. Reliability of
these assay results was further established by significant positive
correlation with plasma calcium (PCa) and the fasting calcium/creati-
nine urinary ratio and by surgical exploration of the neck in ten patients.
In five patients with severe hypercalcemia (> 12.0 mgldl) cimetidine
was discontinued after 5 days because of lack of effect on plasma levels
of Ca and PTH. These patients were cured by surgery. In eight patients
with milder hypercalcemia (10.5 to 12.0 mgldl) cimetidine was given for
Ito 6 months. PCa decreased mildly (3 to 5%) only in three patients, the
maximum decrease being obtained as early as the second week. PiPTH
decreased significantly (25%) only in one patient. In the last patient,
severe hypercalcemia (14.2 mgldl) was controlled by simultaneous
administration of phosphate and cimetidine. After 6 weeks of cimetidine
discontinuation, PCa did not increase from its basal level of 11.2 mg/dl.
Conclusions: Cimetidine does not lower plasma levels of PTH and Ca
and therefore is not useful in the treatment of PHPT.
Familial normocalcemic primary hyperparathyroidism. A. Meyrier, J.
L. Tual, and F. Paillard. Service de Nephrologie, Hôpital Tenon, Paris,
France. We report three patients with normocalcemic primary hyper-
parathyroidism (HPT) in a family. A 20-year-old male complained of
abdominal discomfort and thirst. Blood pressure was 180/100. Serum
calcium (Ca) was 2.4 and phosphorus 1.1 mmoles/liter. He was pre-
scribed calcifediol. He experienced episodes of abdominal pain and
became confused. After a year the following abnormalities were discov-
ered: serum Ca 3.25 mmoles/liter, P 0.77 mmoles/liter, fractional P04
reabsorption 0.71, 24-hr urinary Ca 0.13 mmoles/kg, fasting urinary Cal
creatinine 0.38 (N < 0.30 mmoles/mmole), nephrogenous cAMP 45
pmoles/ml GFR (N < 23). After removal of a parathyroid adenoma
serum Ca and P returned to normal but absorptive hypercalciuria
persisted. His 31-year-old sister had had recurrent renal stones since
she was 17. Serum Ca was 2.5 mmoles/liter, P0.62, fractional reabsorp-
tion of P04 0.70, 24-hr urinary Ca 0.2 mg/kg, fasting urinary Ca/
creatinine 0.38, nephrogenous cAMP 45 pmoles/ml GFR. Following
calcium poor diet, serum Ca remained normal and urinary Ca was
persistently high. After removal of a parathyroid adenoma, serum Ca
and P returned to normal but absorptive hypercalciuria persisted. A 34-
year-old step-brother had hypercalciuria without any other abnormali-
ty. The 59-year-old father of this kindred had had renal stones since the
age of 3. Serum Ca was 2.25 mmoles/liter, P 0.81, P04 fractional
reabsorption 0.73, 24-hr urinary Ca 0.11 mmoles/kg, nephrogenous
cAMP 23. Neck exploration showed only three parathyroid glands, two
of which were hyperplastic and were removed, Hypercalciuria persist-
ed after PTX. These observations are different from cases of familial
HPT in Sipple or Wermer syndromes. They should be added to the 112
cases of familial HPT published since 1936. The persistence of absorp-
tive hypercalciuria that we observed after PTX shows the existence of
some probably acquired disorder of Ca metabolism which could be
linked to increased l-25(OH)2 D1 synthesis, even if stimulation by PTH
is not permanent. Routine family inquiry should be made in primary
HPT.
Bartter's syndrome and polycythemia. R. Montagnac, F. Schillinger,
and G. A. Boffa. Nephrology-Hemodialysis Departement, Centre Ho-
spitalier Général, Troyes et Centre National de Transfusion Sanguine,
Paris, France. After an 18-month treatment with indomethacin arid
potassium chloride, a 29-year-old male with Bartter syndrome (BS) still
presents polycythemia discovered with the disease: hemoglobin 19.5 g/
dl; red blood cells 6.57 106/mm3; hematocrit 53.4%; reticulocytes
105120/mm3; S-R 1-2; serum iron 17 smoles/liter; and transferrin 74
imoIes/liter; hemoglobin electrophoresis and arterial blood gases were
normal. Red cell volume was increased to 2.7 liters (standard 1.65) and
plasma volume was slightly reduced to 2.1 1 (standard 2.6). Serum
erythropoietin (Ep) is 9 mU/mI and its urinary excretion rate 2740 mU/
24 hr (normal range, respectively, 4 to 18 mU/mI and 500 to 1800 mUl24
hr). The association of a high globular mass with normal Ep serum level
and above normal Ep urinary excretion indicates that polycythemia is
secondary to an overproduction of Ep, the secretion sites of which
would remain insensitive to increased erythrocytosis. In BS, hypertro-
phy of the juxtaglomerular apparatus (JGA), known as the major site of
both Ep and renin production, suggests its role in our patient's
persistent polycythemia. This association could be explained either by
the close relationship among renin, Ep, and prostaglandins, or by the
existence of two specific cellular sites in JGA, one responsible for renin
secretion, the other for Ep. In our patient, the strong decrease of renin
activity during indomethacin treatment without simultaneous correc-
tion of erythrocytosis would indicate that the second hypothesis is
correct. The very low incidence of polycythemia in BS could be
explained by the fact that only the renin production site is affected.
Comparison of 1o (OH) vitamin D3 and calcium carbonate for the
control of hyperparathyroidism and hyperaluminemia in patients on
chronic hemodialysis. P. Morinière, Y. Tahiri, H. Dkhissi, A. Pruna,
andA. Fournier. Hôpital Nord, Amiens, France. Twenty-seven reliable
patients on chronic hemodialysis (dialysate aluminum <0.7 /.M/liter for
2 years) whose plasma (p) Ca and P04 had been adequately controlled
for 6 months by high doses of CaCO3 alone (mean SD: 9 5gld) were
randomly divided into two groups: a control group (c group) which was
kept on the same treatment and a "Ia group" in which CaCO3 was
reduced to 3 g/d but in which plasma Ca was kept normal by Ia OH D3
administration (1 1tg/day at the beginning, 0.3 pg/day after 6 months)
while plasma phosphate was kept below 6.0 mgldl by Al(OH)3 (2.7 to 5
gld). The two groups were initially similar with regard to plasma
concentrations of total and ionized calcium, phosphate, 25 OH D.
alkaline phosphatase, C terminal PTH, and aluminum. After 6 months
plasma Ca+ + and PTH were similar (2.16 vs. 2.2 mEq/liter; 350 vs. 478
pg/ml) as was p 25 OH D but P aluminum was higher in the In group (0.8
vs. 2.6 sM/liter). Alk. Pase increased in the c group because of one D
deficient patient (p 25 OH D: 3.9 ng/ml) who developed osteomalacia,
subsequently cured by a physiological dose (75 pg/week) of 25 OH D3.
The incidence of transient hypercalcemia (18 vs. 21 episodes) and
worsening of soft tissue calcifications (three in each group) was the
same in the two groups. In conclusion, (1) hyperparathyroidism of
patients on chronic hemodialysis is not better controlled by In OH D3
than by CaCO3 given at doses maintaining a normal Ca+ + and has the
disadvantage of preventing the decrease of high P aluminum previously
induced by the combination of Al(OH)3 and of the use of a dialysate
aluminum of 2 rmoles/liter. (2) In D deficient patients high doses of
CaCO3 does not prevent osteomalacia.
Coagulation disorders in the nephrotic syndrome (NS). A. Robert, P.
Bertocchio, J. Sampol, A. Gillet, and M. Olmer. Service de Néphrolo-
gie, Laboratoire d'Hematologie, Hôpital de Ia Conception, Marseille,
France. Fifty patients presenting NS and without any medication were
selected for a study on coagulation bearing on physiological inhibitors
such as antithrombine III (AT3), a2 macroglobulin (a2M), a2 antiplas-
mm (a2AP), al antitrypsin (ciIAT) and Cl inhibitor (C11) and on
coagulation factors such as those on the prothrombin complex, the VIII
antigen (VIII Ag), the VIII coagulant (VIIIC), fibrinemia (1) and
plasminogen (P). a2M, a1AT, C1!, VIIIAg and VIIIC levels are in-
creased while AT3, a2AP and P levels are normal. a1AT is elevated in
impure NS: 248 94 mg/dl (N = 200 50, P <0.01); on the other hand,
AT3 is decreased solely in pure NS: 0.87 0.24 (N = I 0.2,P < 0.05).
There is a tendency to thrombocytosis in pure NS: 388,000 144,000
(N = 300,000 100,000, P < 0.02). The presence or absence of renal
insufficiency has no incidence on plasma levels of the parameters
studied. Histological analysis of the results reveals interesting modifica-
tions: a decrease of a,AP 0.77 0.33 (N = I 0.2, P < 0.02) is noted
only in membranous glomerulopathy; in NS with minimal changes AT3
is decreased 0.78 0.21 (N = I 0.2, P < 0.01). The V1IIAgIVIIIC
ratio is normal whereas it is found to be increased in all other cases. A
parallel study of platelet aggregation confirms the tendency of these
patients to hyperaggation (50% of patients) and in particular 16%
spontaneous aggregation. With low doses of ADP (0.5a) there is mainly
hypersensitivity, the percentage of aggregation being 31 23.2 (N = 15
3.5, P < 0.001). For higher doses 1—2, Sn, the percentage of
aggregation is comparable to that of a control group.
Hemodynamic effect of magnesium sulfate in eclampsia. M. Tolani, A.
Tondriaux, P. Fievet, P. Bataille, M. Andrejak, and A. Fournier.
Centre Hospitalo-Universitaire, Amiens, France. We made a hemody-
namic study using a Swan Ganz catheter and a thermodilution tech-
nique before (T0) and 120 mm after (T1) the intravenous injection of
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MgSO4 (priming dose of 4 g followed by 1 g at 90 mm) in three patients
with eclampsia; patients I and 2 were in immediate postpartum (with
pulmonary edema in patient 1) and patient 3 at her 27th week with
oliguria due to extracapillary glomerulonephritis. The results are:
wP
Mean
SEM
MAP
mm Hg
SVR
dIsIcm5
CO
I/mm
SPP
mm Hg
mm
Hg
WB
ml
T0 133 6.80 1215 118 8.8 1.1 20 1.1 12 1 0
T1 105 3.7 1368 127 6.4 0.7 15 1 9 1 30 50
Abbreviations: MAP, mean arterial pressure; SVR, systemic vascu-
lar resistance; CO, cardiac output; SPP, systolic pulmonary pressure;
WP, wedge pressure; WB, water balance.
In patient 1, a diuretic effect occurred after 150 mm leading 6 hr later to
a negative WB, a greater decrease in CO, and an increase in SVR;
pulmonary edema simultaneously cleared. In patient 2 the diuretic
effect occurred only after 8 hr. In patient 3 no increase in diuresis was
observed until 500 mg of furosemide was given. In conclusion, (I) in
eclampsia with increased CO and normal SVR, MgSO4 decreased BP
by decreasing CO since there was no change in SVR. (2) The decrease
in CO masked the systemic vasodilating effect. It was not due to a
negative inotropic effect since there was no increase in WP. This
implied a decrease in preload due to increased venous compliance since
no significant diuretic effect was observed during the first 150 mm. (3)
MgSO4 appeared to be a drug particularly suitable for treatment of
eclampsia complicated by pulmonary edema since besides its anticon-
vulsive properties, it lowered BP, increased venous compliance, and
might have increased diuresis.
